Literature DB >> 2559654

Biochemical characteristics and physiological significance of major DNA topoisomerases.

J A Sutcliffe1, T D Gootz, J F Barrett.   

Abstract

Mesh:

Substances:

Year:  1989        PMID: 2559654      PMCID: PMC172816          DOI: 10.1128/AAC.33.12.2027

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  113 in total

1.  Expression of yeast DNA topoisomerase I can complement a conditional-lethal DNA topoisomerase I mutation in Escherichia coli.

Authors:  M A Bjornsti; J C Wang
Journal:  Proc Natl Acad Sci U S A       Date:  1987-12       Impact factor: 11.205

2.  Involvement of DNA topoisomerase I in transcription of human ribosomal RNA genes.

Authors:  H Zhang; J C Wang; L F Liu
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

3.  Cloning and sequencing of the Escherichia coli gyrA gene coding for the A subunit of DNA gyrase.

Authors:  S L Swanberg; J C Wang
Journal:  J Mol Biol       Date:  1987-10-20       Impact factor: 5.469

4.  Mechanism of illegitimate recombination: common sites for recombination and cleavage mediated by E. coli DNA gyrase.

Authors:  H Ikeda; I Kawasaki; M Gellert
Journal:  Mol Gen Genet       Date:  1984

5.  A high affinity topoisomerase I binding sequence is clustered at DNAase I hypersensitive sites in Tetrahymena R-chromatin.

Authors:  B J Bonven; E Gocke; O Westergaard
Journal:  Cell       Date:  1985-06       Impact factor: 41.582

6.  A type-II DNA topoisomerase and a catenating protein from the transplantable VX2 carcinoma.

Authors:  G F Riou; M Gabillot; M Barrois; F Breitburd; G Orth
Journal:  Eur J Biochem       Date:  1985-02-01

7.  Purification and characterization of a type II DNA topoisomerase from bovine calf thymus.

Authors:  B D Halligan; K A Edwards; L F Liu
Journal:  J Biol Chem       Date:  1985-02-25       Impact factor: 5.157

8.  Drosophila DNA topoisomerase I is associated with transcriptionally active regions of the genome.

Authors:  G Fleischmann; G Pflugfelder; E K Steiner; K Javaherian; G C Howard; J C Wang; S C Elgin
Journal:  Proc Natl Acad Sci U S A       Date:  1984-11       Impact factor: 11.205

9.  Topoisomerase II is a structural component of mitotic chromosome scaffolds.

Authors:  W C Earnshaw; B Halligan; C A Cooke; M M Heck; L F Liu
Journal:  J Cell Biol       Date:  1985-05       Impact factor: 10.539

10.  The genetic control of DNA supercoiling in Salmonella typhimurium.

Authors:  S M Richardson; C F Higgins; D M Lilley
Journal:  EMBO J       Date:  1984-08       Impact factor: 11.598

View more
  29 in total

1.  Conditional growth of Escherichia coli caused by expression of vaccinia virus DNA topoisomerase I.

Authors:  M E Fernandez-Beros; Y C Tse-Dinh
Journal:  J Bacteriol       Date:  1992-11       Impact factor: 3.490

2.  Autonomous parvovirus DNA replication requires topoisomerase I and its activity is increased during infection.

Authors:  M L Gu; S L Rhode
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

Review 3.  Inhibitory effects of quinolone antibacterial agents on eucaryotic topoisomerases and related test systems.

Authors:  T D Gootz; J F Barrett; J A Sutcliffe
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

Review 4.  In vitro assays used to measure the activity of topoisomerases.

Authors:  J F Barrett; J A Sutcliffe; T D Gootz
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

5.  Mechanisms of clinical resistance to fluoroquinolones in Staphylococcus aureus.

Authors:  N Nakanishi; S Yoshida; H Wakebe; M Inoue; T Yamaguchi; S Mitsuhashi
Journal:  Antimicrob Agents Chemother       Date:  1991-12       Impact factor: 5.191

6.  Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.

Authors:  V Revel-Viravau; Q C Truong; N Moreau; V Jarlier; W Sougakoff
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

Review 7.  Mechanisms of resistance to quinolones.

Authors:  E Cambau; L Gutmann
Journal:  Drugs       Date:  1993       Impact factor: 9.546

8.  Biological characterization of cyclothialidine, a new DNA gyrase inhibitor.

Authors:  N Nakada; H Shimada; T Hirata; Y Aoki; T Kamiyama; J Watanabe; M Arisawa
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

Review 9.  Clinical pharmacokinetics of ciprofloxacin.

Authors:  K Vance-Bryan; D R Guay; J C Rotschafer
Journal:  Clin Pharmacokinet       Date:  1990-12       Impact factor: 6.447

10.  Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.

Authors:  E Cambau; F Bordon; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.